Two small studies conducted at New York University and the University of Texas have found that subjects who had received the standard two doses of the Pfizer vaccine for the coronavirus will largely succeed in warding off the South African coronavirus variant.
“In a U.S. study of 20 vaccine recipients, researchers at the University of Texas Medical Branch at Galveston found that the vaccine neutralizes the virus with the N501Y and E484K mutation. Researchers at New York University, investigating the South African variant in a study of 10 people, also reportedly found the immune antibodies made by the vaccine were still able to destroy the virus,” The Mirror reported.
.png)
.png)
